Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review

Detalhes bibliográficos
Autor(a) principal: Souza, Karolayne Silva
Data de Publicação: 2020
Outros Autores: Silva, Milena Roberta Freire da, Silva, Sivoneide Maria da, Oliveira, Maria Betânia Melo de, Lima, Ana Vitória Araújo, Sá, Rafael Artur de Queiroz Cavalcanti de, Ramos, Bárbara de Azevedo, Silva, Jaqueline dos Santos, Santos , Graziele dos, Lima, Felicson Leonardo Oliveira, Silva, Rodrigo Reges dos Santos, Brito, Leandro Paes de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/8955
Resumo: Introduction: COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, responsible for mainly affecting the lungs and triggering respiratory pathologies, as well as developing liver, neurological and gastrointestinal problems. The objective of this systematic review was to conduct a survey of studies with the main laboratory markers of patients with COVID-19 relating the abnormalities of these results to the clinical prediction of severe and non-severe patients. Methodology: This study was conducted following the methodological guidelines of a Systematic Review according to the PRISMA protocol, of which searches were carried out in the electronic databases PubMed, LILACS, EMBASE, Science, medRxiv, and bioRxiv, using the keywords- keys: "SARS-CoV-2" OR "COVID- 19" OR "Coronavirus" AND "Laboratory Parameters" AND "Exams" OR "Laboratory". Eligible articles published from January 2020 to May 20, 2020 were used, without language restrictions containing hematological, biochemical and immunological laboratory data. Results: According to this review, 16 eligible articles were selected. The main abnormalities were observed in critically ill patients with significant changes in some hematological, biochemical and immunological parameters, such as: ferritin, lymphocytes, D-Dimer, LDH, AST, PCR, Procalcitonin, TcnI and IL-6. Conclusion: The present study demonstrates the relevance of laboratory tests to assist healthcare professionals in carrying out necessary measures and appropriate therapeutic approaches for the treatment of patients infected with coronavirus.
id UNIFEI_d67e7e870b38ed57baa0de55d3f8235e
oai_identifier_str oai:ojs.pkp.sfu.ca:article/8955
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic reviewAsociación de los principales parámetros hematológicos, bioquímicos e inmunológicos en pacientes críticos y no críticos con COVID-19: una revisión sistemáticaAssociação dos principais parâmetros hematológicos, bioquímicos e imunológicos em pacientes graves e não graves com COVID-19: uma revisão sistemáticaSARS-CoV-2LaboratoryBiomarkers.SARS-CoV-2LaboratorioBiomarcadores.SARS-CoV-2LaboratórioBiomarcadores.Introduction: COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, responsible for mainly affecting the lungs and triggering respiratory pathologies, as well as developing liver, neurological and gastrointestinal problems. The objective of this systematic review was to conduct a survey of studies with the main laboratory markers of patients with COVID-19 relating the abnormalities of these results to the clinical prediction of severe and non-severe patients. Methodology: This study was conducted following the methodological guidelines of a Systematic Review according to the PRISMA protocol, of which searches were carried out in the electronic databases PubMed, LILACS, EMBASE, Science, medRxiv, and bioRxiv, using the keywords- keys: "SARS-CoV-2" OR "COVID- 19" OR "Coronavirus" AND "Laboratory Parameters" AND "Exams" OR "Laboratory". Eligible articles published from January 2020 to May 20, 2020 were used, without language restrictions containing hematological, biochemical and immunological laboratory data. Results: According to this review, 16 eligible articles were selected. The main abnormalities were observed in critically ill patients with significant changes in some hematological, biochemical and immunological parameters, such as: ferritin, lymphocytes, D-Dimer, LDH, AST, PCR, Procalcitonin, TcnI and IL-6. Conclusion: The present study demonstrates the relevance of laboratory tests to assist healthcare professionals in carrying out necessary measures and appropriate therapeutic approaches for the treatment of patients infected with coronavirus.Introducción: COVID-19 es una enfermedad infecciosa causada por el virus SARS-CoV-2, responsable de afectar principalmente a los pulmones y desencadenar patologías respiratorias, además de desarrollar problemas hepáticos, neurológicos y gastrointestinales. El objetivo de esta revisión sistemática fue realizar una encuesta de estudios con los principales marcadores de laboratorio de pacientes con COVID-19 relacionando las anomalías de estos resultados con la predicción clínica de pacientes graves y no graves. Metodología: Este estudio se realizó siguiendo los lineamientos metodológicos de una Revisión Sistemática según el protocolo PRISMA, de la cual se realizaron búsquedas en las bases de datos electrónicas PubMed, LILACS, EMBASE, Science, medRxiv y bioRxiv, utilizando las palabras clave- claves: "SARS-CoV-2" O "COVID-19" O "Coronavirus" Y "Parámetros de laboratorio" Y "Exámenes" O "Laboratorio". Se utilizaron artículos elegibles publicados desde enero de 2020 hasta el 20 de mayo de 2020, sin restricciones de idioma, que contenían datos de laboratorio hematológicos, bioquímicos e inmunológicos. Resultados: Según esta revisión, se seleccionaron 16 artículos elegibles. Las principales anomalías se observaron en pacientes críticos con cambios significativos en algunos parámetros hematológicos, bioquímicos e inmunológicos, como: ferritina, linfocitos, D-Dimer, LDH, AST, PCR, Procalcitonina, TcnI e IL-6. Conclusión: El presente estudio demuestra la relevancia de las pruebas de laboratorio para ayudar a los profesionales sanitarios a llevar a cabo las medidas necesarias y los enfoques terapéuticos adecuados para el tratamiento de pacientes infectados por coronavirus.Introdução: A COVID-19 é uma doença infectocontagiosa causada pelo vírus SARS-CoV-2, responsável por acometer principalmente os pulmões e desencadear patologias respiratórias, como também desenvolver problemas hepáticos, neurológicas e gastrointestinais. O objetivo desta revisão sistemática foi realizar um levantamento de estudos com os principais marcadores laboratoriais de pacientes com COVID-19 relacionando as anormalidades destes resultados com a predição clínica de pacientes graves e não graves. Metodologia: Este estudo foi conduzido seguindo as diretrizes metodológicas de uma Revisão Sistemática de acordo com o protocolo PRISMA, dos quais, realizou-se buscas nas bases eletrônicas PubMed, LILACS, EMBASE, Science, medRxiv, e bioRxiv, utilizando as palavras-chaves: "SARS-CoV-2" OR "COVID-19" OR "Coronavirus" AND “Laboratory Parameters” AND "Exams" OR "Laboratory". Foram utilizados artigos elegíveis publicados a partir de janeiro de 2020 até 20 de maio de 2020, sem restrições de idioma contendo dados laboratoriais hematológicos, bioquímicos e imunológicos. Resultados: De acordo com esta revisão foram selecionados 16 artigos elegíveis. As principais anormalidades foram observadas em pacientes graves com alterações expressivas em alguns parâmetros hematológicos, bioquímicos e imunológicos, sendo estes: ferritina, linfócitos, D-Dímero, LDH, AST, PCR, Procalcitonina, TcnI e IL-6. Conclusão: O presente estudo demonstra a relevância dos exames laboratoriais para auxiliar os profissionais da área da saúde na execução de medidas necessárias e condutas terapêuticas adequadas  para o tratamento de pacientes infectados pelo coronavírus.Research, Society and Development2020-11-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/895510.33448/rsd-v9i11.8955Research, Society and Development; Vol. 9 No. 11; e2619118955Research, Society and Development; Vol. 9 Núm. 11; e2619118955Research, Society and Development; v. 9 n. 11; e26191189552525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/8955/9115Copyright (c) 2020 Karolayne Silva Souza; Milena Roberta Freire da Silva; Sivoneide Maria da Silva; Maria Betânia Melo de Oliveira; Ana Vitória Araújo Lima; Rafael Artur de Queiroz Cavalcanti de Sá; Bárbara de Azevedo Ramos; Jaqueline dos Santos Silva; Graziele dos Santos ; Felicson Leonardo Oliveira Lima; Rodrigo Rege dos Santos Silva; Leandro Paes de Britohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouza, Karolayne Silva Silva, Milena Roberta Freire da Silva, Sivoneide Maria da Oliveira, Maria Betânia Melo de Lima, Ana Vitória Araújo Sá, Rafael Artur de Queiroz Cavalcanti de Ramos, Bárbara de Azevedo Silva, Jaqueline dos Santos Santos , Graziele dos Lima, Felicson Leonardo Oliveira Silva, Rodrigo Reges dos Santos Brito, Leandro Paes de 2020-12-10T23:37:57Zoai:ojs.pkp.sfu.ca:article/8955Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:31:18.953371Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
Asociación de los principales parámetros hematológicos, bioquímicos e inmunológicos en pacientes críticos y no críticos con COVID-19: una revisión sistemática
Associação dos principais parâmetros hematológicos, bioquímicos e imunológicos em pacientes graves e não graves com COVID-19: uma revisão sistemática
title Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
spellingShingle Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
Souza, Karolayne Silva
SARS-CoV-2
Laboratory
Biomarkers.
SARS-CoV-2
Laboratorio
Biomarcadores.
SARS-CoV-2
Laboratório
Biomarcadores.
title_short Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
title_full Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
title_fullStr Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
title_full_unstemmed Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
title_sort Association of the main hematological, biochemical and immunological parameters in critical and non-critical patients with COVID-19: a systematic review
author Souza, Karolayne Silva
author_facet Souza, Karolayne Silva
Silva, Milena Roberta Freire da
Silva, Sivoneide Maria da
Oliveira, Maria Betânia Melo de
Lima, Ana Vitória Araújo
Sá, Rafael Artur de Queiroz Cavalcanti de
Ramos, Bárbara de Azevedo
Silva, Jaqueline dos Santos
Santos , Graziele dos
Lima, Felicson Leonardo Oliveira
Silva, Rodrigo Reges dos Santos
Brito, Leandro Paes de
author_role author
author2 Silva, Milena Roberta Freire da
Silva, Sivoneide Maria da
Oliveira, Maria Betânia Melo de
Lima, Ana Vitória Araújo
Sá, Rafael Artur de Queiroz Cavalcanti de
Ramos, Bárbara de Azevedo
Silva, Jaqueline dos Santos
Santos , Graziele dos
Lima, Felicson Leonardo Oliveira
Silva, Rodrigo Reges dos Santos
Brito, Leandro Paes de
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Souza, Karolayne Silva
Silva, Milena Roberta Freire da
Silva, Sivoneide Maria da
Oliveira, Maria Betânia Melo de
Lima, Ana Vitória Araújo
Sá, Rafael Artur de Queiroz Cavalcanti de
Ramos, Bárbara de Azevedo
Silva, Jaqueline dos Santos
Santos , Graziele dos
Lima, Felicson Leonardo Oliveira
Silva, Rodrigo Reges dos Santos
Brito, Leandro Paes de
dc.subject.por.fl_str_mv SARS-CoV-2
Laboratory
Biomarkers.
SARS-CoV-2
Laboratorio
Biomarcadores.
SARS-CoV-2
Laboratório
Biomarcadores.
topic SARS-CoV-2
Laboratory
Biomarkers.
SARS-CoV-2
Laboratorio
Biomarcadores.
SARS-CoV-2
Laboratório
Biomarcadores.
description Introduction: COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, responsible for mainly affecting the lungs and triggering respiratory pathologies, as well as developing liver, neurological and gastrointestinal problems. The objective of this systematic review was to conduct a survey of studies with the main laboratory markers of patients with COVID-19 relating the abnormalities of these results to the clinical prediction of severe and non-severe patients. Methodology: This study was conducted following the methodological guidelines of a Systematic Review according to the PRISMA protocol, of which searches were carried out in the electronic databases PubMed, LILACS, EMBASE, Science, medRxiv, and bioRxiv, using the keywords- keys: "SARS-CoV-2" OR "COVID- 19" OR "Coronavirus" AND "Laboratory Parameters" AND "Exams" OR "Laboratory". Eligible articles published from January 2020 to May 20, 2020 were used, without language restrictions containing hematological, biochemical and immunological laboratory data. Results: According to this review, 16 eligible articles were selected. The main abnormalities were observed in critically ill patients with significant changes in some hematological, biochemical and immunological parameters, such as: ferritin, lymphocytes, D-Dimer, LDH, AST, PCR, Procalcitonin, TcnI and IL-6. Conclusion: The present study demonstrates the relevance of laboratory tests to assist healthcare professionals in carrying out necessary measures and appropriate therapeutic approaches for the treatment of patients infected with coronavirus.
publishDate 2020
dc.date.none.fl_str_mv 2020-11-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8955
10.33448/rsd-v9i11.8955
url https://rsdjournal.org/index.php/rsd/article/view/8955
identifier_str_mv 10.33448/rsd-v9i11.8955
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8955/9115
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 11; e2619118955
Research, Society and Development; Vol. 9 Núm. 11; e2619118955
Research, Society and Development; v. 9 n. 11; e2619118955
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052781172883456